BlackRock’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-133,256
| Closed | -$93.1K | – | 5537 |
|
|
2023
Q1 | $93.1K | Sell |
133,256
-3,044
| -2% | -$2.13K | ﹤0.01% | 4889 |
|
|
2022
Q4 | $123K | Sell |
136,300
-15,880
| -10% | -$14.3K | ﹤0.01% | 4895 |
|
|
2022
Q3 | $913K | Buy |
152,180
+14,940
| +11% | +$89.6K | ﹤0.01% | 4423 |
|
|
2022
Q2 | $568K | Buy |
137,240
+3,109
| +2% | +$12.9K | ﹤0.01% | 4645 |
|
|
2022
Q1 | $509K | Sell |
134,131
-17,122
| -11% | -$65K | ﹤0.01% | 4778 |
|
|
2021
Q4 | $681K | Buy |
151,253
+547
| +0.4% | +$2.46K | ﹤0.01% | 4711 |
|
|
2021
Q3 | $702K | Buy |
150,706
+25,332
| +20% | +$118K | ﹤0.01% | 4600 |
|
|
2021
Q2 | $884K | Sell |
125,374
-458,145
| -79% | -$3.23M | ﹤0.01% | 4483 |
|
|
2021
Q1 | $3.45M | Buy |
583,519
+11,004
| +2% | +$65K | ﹤0.01% | 4036 |
|
|
2020
Q4 | $2.64M | Buy |
572,515
+26,396
| +5% | +$122K | ﹤0.01% | 3877 |
|
|
2020
Q3 | $2.12M | Sell |
546,119
-5,247
| -1% | -$20.4K | ﹤0.01% | 3790 |
|
|
2020
Q2 | $15.9M | Buy |
551,366
+337,754
| +158% | +$9.71M | ﹤0.01% | 2866 |
|
|
2020
Q1 | $4.6M | Buy |
213,612
+50,079
| +31% | +$1.08M | ﹤0.01% | 3332 |
|
|
2019
Q4 | $3.22M | Buy |
163,533
+103,563
| +173% | +$2.04M | ﹤0.01% | 3579 |
|
|
2019
Q3 | $900K | Buy |
+59,970
| New | +$900K | ﹤0.01% | 3967 |
|